Celcuity (CELC) Free Cash Flow (2016 - 2025)
Celcuity (CELC) reported Free Cash Flow of -$36.5 million for Q4 2025, down 31.05% on a YoY basis from -$52.9 million in Q4 2024, and up 18.84% quarter-over-quarter from -$44.9 million in Q3 2025.
Celcuity (CELC) Free Cash Flow (2016 - 2025) Analysis & Trends
Celcuity has reported Free Cash Flow for 10 years, with the latest figure at -$36.5 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 31.05% year-over-year to -$36.5 million; the trailing twelve-month figure through Dec 2025 stood at -$153.5 million (down 83.39% YoY), and the FY2025 full-year result was -$153.5 million, down 83.39% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$36.5 million, up from -$44.9 million in the prior quarter.
- The five-year high for Free Cash Flow was -$2.6 million in Q1 2021, with the low at -$44.9 million in Q3 2025.
- Historically, Free Cash Flow has averaged -$17.4 million across 5 years, with a median of -$12.8 million in 2023.
- Annual changes were most pronounced in 2021 — Free Cash Flow plunged 384.75% — and 2023, when it gained 14.54%.
- Celcuity's Free Cash Flow stood at -$6.1 million in 2021, then tumbled by 56.36% to -$9.6 million in 2022, then sank by 93.6% to -$18.6 million in 2023, then slumped by 49.8% to -$27.8 million in 2024, then slumped by 31.05% to -$36.5 million in 2025.
- The last three Free Cash Flow figures came in at -$36.5 million (Q4 2025), -$44.9 million (Q3 2025), and -$36.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 63,220.27 |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -36.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.45 Mn |
| Dec 31, 2025 | -36.45 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Jun 30, 2025 | -36.25 Mn |
| Jun 30, 2025 | -36.25 Mn |
| Mar 31, 2025 | -35.91 Mn |
| Mar 31, 2025 | -35.91 Mn |
| Dec 31, 2024 | -27.82 Mn |
| Dec 31, 2024 | -27.82 Mn |
| Sep 30, 2024 | -20.61 Mn |
| Sep 30, 2024 | -20.61 Mn |
| Jun 30, 2024 | -18.13 Mn |
| Jun 30, 2024 | -18.13 Mn |
| Mar 31, 2024 | -17.16 Mn |
| Mar 31, 2024 | -17.16 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.80 Mn |
| Sep 30, 2023 | -12.80 Mn |